Ketoconazole &#160; Xi Nghezi (Q407883)

retrieved ^{Xi Nghezi}

27 Nyenyenyani 2018

has use ^{Xi Nghezi}

medication ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

DrugBank ^{Xi Nghezi}

DrugBank ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

Ketoconazole (Xi Nghezi)

publication date ^{Xi Nghezi}

17 Hukuri 2015

chemical structure ^{Xi Nghezi}

Ketoconazol-Enantiomere Strukturformeln.png
2,877 × 2,141; 44 KB

1 reference

imported from Wikimedia project ^{Xi Nghezi}

German Wikipedia ^{Xi Nghezi}

ntikelo

530.148761 dalton

1 reference

stated in ^{Xi Nghezi}

PubChem ^{Xi Nghezi}

PubChem CID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

ketoconazole (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

chemical formula ^{Xi Nghezi}

C₂₆H₂₈Cl₂N₄O₄

1 reference

stated in ^{Xi Nghezi}

PubChem ^{Xi Nghezi}

PubChem CID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

ketoconazole (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

canonical SMILES ^{Xi Nghezi}

CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl

1 reference

stated in ^{Xi Nghezi}

PubChem ^{Xi Nghezi}

PubChem CID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

https://www.whocc.no/atc_ddd_index/?code=J02AB02

title ^{Xi Nghezi}

ketoconazole (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

defined daily dose ^{Xi Nghezi}

0.2 gram

route of administration ^{Xi Nghezi}

oral administration ^{Xi Nghezi}

1 reference

reference URL ^{Xi Nghezi}

0.4 gram

route of administration ^{Xi Nghezi}

intravaginal administration ^{Xi Nghezi}

1 reference

reference URL ^{Xi Nghezi}

https://www.whocc.no/atc_ddd_index/?code=G01AF11

active ingredient in ^{Xi Nghezi}

Ketoconazole Hra ^{Xi Nghezi}

1 reference

European Medicines Agency product number ^{Xi Nghezi}

EMEA/H/C/003906

reference URL ^{Xi Nghezi}

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003906/human_med_001814.jsp

retrieved ^{Xi Nghezi}

22 Nyenyankulu 2017

found in taxon ^{Xi Nghezi}

Streptomyces hygroscopicus ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain ^{Xi Nghezi}

Anomospermum grandifolium ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

New triterpene glycosides from the stems of Anomospermum grandifolium ^{Xi Nghezi}

Dendrodochium ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

Polyhydroxy Cyclohexanols from a Dendrodochium sp. Fungus Associated with the Sea Cucumber Holothuria nobilis Selenka ^{Xi Nghezi}

medical condition treated ^{Xi Nghezi}

vulvovaginal candidiasis ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

oral candidiasis ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

coccidioidomycosis ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

Leyiximeniyasisi

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

dermatomycosis ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

chronic mucocutaneous candidiasis ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

paracoccidioidomycosis ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

blastomycosis ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

candidiasis ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

tinea ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

tinea pedis ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

histoplasmosis ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

fungal infectious disease ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

seborrhoeic dermatitis ^{Xi Nghezi}

2 references

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

stated in ^{Xi Nghezi}

Drug Indications Extracted from FAERS ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

2 Nhlangula 2018

pityriasis versicolor ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

cutaneous candidiasis ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

13 N'wendzamhala 2016

seborrheic infantile dermatitis ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

Drug Indications Extracted from FAERS ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

2 Nhlangula 2018

significant drug interaction ^{Xi Nghezi}

domperidone ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

ergotamine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

ergotism ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

pimozide ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

buprenorphine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

simvastatin ^{Xi Nghezi}

side effect ^{Xi Nghezi}

rhabdomyolysis ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

simvastatin ^{Xi Nghezi}

side effect ^{Xi Nghezi}

muscular disease ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

quetiapine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

alfentanil ^{Xi Nghezi}

side effect ^{Xi Nghezi}

central respiratory depression ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

fluticasone ^{Xi Nghezi}

side effect ^{Xi Nghezi}

Decreased circulating cortisol level ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

cyclosporine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

kidney failure ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

cyclosporine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

cholestasis ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

cyclosporine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

paresthesia ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

dasatinib monohydrate ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

saquinavir ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

docetaxel trihydrate ^{Xi Nghezi}

side effect ^{Xi Nghezi}

thrombocytopenia ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

docetaxel trihydrate ^{Xi Nghezi}

side effect ^{Xi Nghezi}

leukopenia ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

docetaxel trihydrate ^{Xi Nghezi}

side effect ^{Xi Nghezi}

fever ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

docetaxel trihydrate ^{Xi Nghezi}

side effect ^{Xi Nghezi}

diarrhea ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

docetaxel trihydrate ^{Xi Nghezi}

side effect ^{Xi Nghezi}

anemia ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

nifedipine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

sinus bradycardia ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

nifedipine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

hypotension ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

nifedipine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

acute kidney injury ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

sirolimus ^{Xi Nghezi}

side effect ^{Xi Nghezi}

leukopenia ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

sirolimus ^{Xi Nghezi}

side effect ^{Xi Nghezi}

anemia ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

sirolimus ^{Xi Nghezi}

side effect ^{Xi Nghezi}

thrombocytopenia ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

sirolimus ^{Xi Nghezi}

side effect ^{Xi Nghezi}

Achor-Smith syndrom ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

sirolimus ^{Xi Nghezi}

side effect ^{Xi Nghezi}

diarrhea ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

sufentanil ^{Xi Nghezi}

side effect ^{Xi Nghezi}

central respiratory depression ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

pazopanib ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

crizotinib ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

eliglustat ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

ivabradine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

dabrafenib ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

venlafaxine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

tolterodine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

tacrolimus ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

famotidine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

salmeterol ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

vardenafil ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

Sildenafil ^{Xi Nghezi}

side effect ^{Xi Nghezi}

headache disorder ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

Sildenafil ^{Xi Nghezi}

side effect ^{Xi Nghezi}

flushing ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

Sildenafil ^{Xi Nghezi}

side effect ^{Xi Nghezi}

priapism ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

nicardipine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

lightheadedness ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

nicardipine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

hypotension ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

nicardipine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

flushing ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

nicardipine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

headache disorder ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

nicardipine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

peripheral edema ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

disopyramide ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

sunitinib ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

ranolazine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

torsades de pointes ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

ranolazine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

cardiotoxicity ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

ranolazine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

ranolazine ^{Xi Nghezi}

side effect ^{Xi Nghezi}

pulseless electrical activity ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

nilotinib ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

atorvastatin ^{Xi Nghezi}

side effect ^{Xi Nghezi}

rhabdomyolysis ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

atorvastatin ^{Xi Nghezi}

side effect ^{Xi Nghezi}

muscular disease ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

atazanavir ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

lopinavir ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

ritonavir ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

dronedarone ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

established ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

bedaquiline ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

probably ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

panobinostat ^{Xi Nghezi}

side effect ^{Xi Nghezi}

long QT syndrome ^{Xi Nghezi}

1 reference

sourcing circumstances ^{Xi Nghezi}

hypothetically ^{Xi Nghezi}

stated in ^{Xi Nghezi}

A reference set of clinically relevant adverse drug-drug interactions ^{Xi Nghezi}

physically interacts with ^{Xi Nghezi}

Potassium voltage-gated channel subfamily A member 10 ^{Xi Nghezi}

subject has role ^{Xi Nghezi}

channel blocker ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

IUPHAR/BPS Guide to PHARMACOLOGY ^{Xi Nghezi}

Guide to Pharmacology Ligand ID ^{Xi Nghezi}

2568

language of work or name ^{Xi Nghezi}

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

retrieved ^{Xi Nghezi}

17 Mhawuri 2016

legal status (medicine) ^{Xi Nghezi}

boxed warning ^{Xi Nghezi}

1 reference

reference URL ^{Xi Nghezi}

title ^{Xi Nghezi}

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (Xi Nghezi)

pregnancy category ^{Xi Nghezi}

Australian pregnancy category B3 ^{Xi Nghezi}

1 reference

imported from Wikimedia project ^{Xi Nghezi}

English Wikipedia ^{Xi Nghezi}

US pregnancy category C ^{Xi Nghezi}

1 reference

imported from Wikimedia project ^{Xi Nghezi}

English Wikipedia ^{Xi Nghezi}

LiverTox likelihood score ^{Xi Nghezi}

LiverTox toxicity likelihood category A ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

LiverTox ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

8 Dzivamusoko 2021

reference URL ^{Xi Nghezi}

https://www.ncbi.nlm.nih.gov/books/n/livertox/Ketoconazole

last update ^{Xi Nghezi}

17 Mudyaxihi 2017

subject has role ^{Xi Nghezi}

xenobiotic-transporting ATPase inhibitor ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

5 Nyenyankulu 2018

cytochrome P-450 CYP3A inhibitors ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

Medical Subject Headings ^{Xi Nghezi}

MeSH descriptor ID ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

15 Nyenyankulu 2018

antifungal ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

Medical Subject Headings ^{Xi Nghezi}

MeSH descriptor ID ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

15 Nyenyankulu 2018

14-alpha demethylase inhibitor ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

Medical Subject Headings ^{Xi Nghezi}

MeSH descriptor ID ^{Xi Nghezi}

http://datos.bne.es/tema/XX533522.html

retrieved ^{Xi Nghezi}

15 Nyenyankulu 2018

MCN code ^{Xi Nghezi}

2934.99.31

0 references

has part(s) ^{Xi Nghezi}

(2R,4S)-ketoconazole ^{Xi Nghezi}

0 references

(2S,4R)-ketoconazole ^{Xi Nghezi}

0 references

Ntlawa wa Commons

Ketoconazole

0 references

Identifiers

National Library of Spain ID ^{Xi Nghezi}

XX533522

1 reference

reference URL ^{Xi Nghezi}

InChI ^{Xi Nghezi}

InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3

1 reference

stated in ^{Xi Nghezi}

PubChem ^{Xi Nghezi}

PubChem CID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

XMAYWYJOQHXEEK-UHFFFAOYSA-N

title ^{Xi Nghezi}

ketoconazole (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

InChIKey ^{Xi Nghezi}

2 references

stated in ^{Xi Nghezi}

PubChem ^{Xi Nghezi}

PubChem CID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

ketoconazole (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

stated in ^{Xi Nghezi}

ChEBI release 2020-09-01 ^{Xi Nghezi}

CAS Registry Number ^{Xi Nghezi}

65277-42-1

1 reference

stated in ^{Xi Nghezi}

DrugBank ^{Xi Nghezi}

DrugBank ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

Ketoconazole (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

79156-75-5

0 references

ChemSpider ID ^{Xi Nghezi}

3691

1 reference

stated in ^{Xi Nghezi}

ChemSpider ^{Xi Nghezi}

ChemSpider ID ^{Xi Nghezi}

3691

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

cis-1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1h-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

PubChem CID ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

PubChem ^{Xi Nghezi}

PubChem CID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

ketoconazole (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

Reaxys registry number ^{Xi Nghezi}

634785

1 reference

stated in ^{Xi Nghezi}

ChEBI ^{Xi Nghezi}

ChEBI ID ^{Xi Nghezi}

48339

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

Gmelin number ^{Xi Nghezi}

1713206

0 references

ChEBI ID ^{Xi Nghezi}

48339

mapping relation type ^{Xi Nghezi}

exact match ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

ChEBI ^{Xi Nghezi}

ChEBI ID ^{Xi Nghezi}

48339

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

ChEMBL ID ^{Xi Nghezi}

CHEMBL157101

1 reference

stated in ^{Xi Nghezi}

ChEMBL ^{Xi Nghezi}

ChEMBL ID ^{Xi Nghezi}

CHEMBL157101

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

CHEMBL157101 (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

UniChem compound ID ^{Xi Nghezi}

1100519

1 reference

stated in ^{Xi Nghezi}

UniChem ^{Xi Nghezi}

ICSC ID ^{Xi Nghezi}

1700

0 references

ZVG number ^{Xi Nghezi}

151402

0 references

DSSTox substance ID ^{Xi Nghezi}

DTXSID20273956

1 reference

stated in ^{Xi Nghezi}

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^{Xi Nghezi}

DSSTOX compound identifier ^{Xi Nghezi}

DTXCID90196446

0 references

LiverTox ID ^{Xi Nghezi}

0 references

NSC number ^{Xi Nghezi}

757081

0 references

317629

0 references

EC number ^{Xi Nghezi}

265-667-4

1 reference

stated in ^{Xi Nghezi}

ECHA Substance Infocard database ^{Xi Nghezi}

ECHA Substance Infocard ID ^{Xi Nghezi}

100.059.680

retrieved ^{Xi Nghezi}

27 N'wendzamhala 2018

title ^{Xi Nghezi}

Ketoconazole (Xi Nghezi)

quotation ^{Xi Nghezi}

CAS no.: 65277-42-1 (Xi Nghezi)

ECHA Substance Infocard ID ^{Xi Nghezi}

100.059.680

1 reference

stated in ^{Xi Nghezi}

ECHA Substance Infocard database ^{Xi Nghezi}

ECHA Substance Infocard ID ^{Xi Nghezi}

100.059.680

retrieved ^{Xi Nghezi}

27 N'wendzamhala 2018

title ^{Xi Nghezi}

Ketoconazole (Xi Nghezi)

quotation ^{Xi Nghezi}

CAS no.: 65277-42-1 (Xi Nghezi)

ATC code ^{Xi Nghezi}

J02AB02

1 reference

stated in ^{Xi Nghezi}

DrugBank ^{Xi Nghezi}

DrugBank ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

Ketoconazole (Xi Nghezi)

publication date ^{Xi Nghezi}

17 Hukuri 2015

D01AC08

1 reference

stated in ^{Xi Nghezi}

DrugBank ^{Xi Nghezi}

DrugBank ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

Ketoconazole (Xi Nghezi)

publication date ^{Xi Nghezi}

17 Hukuri 2015

G01AF11

1 reference

stated in ^{Xi Nghezi}

DrugBank ^{Xi Nghezi}

DrugBank ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

Ketoconazole (Xi Nghezi)

publication date ^{Xi Nghezi}

17 Hukuri 2015

Guide to Pharmacology Ligand ID ^{Xi Nghezi}

2568

1 reference

stated in ^{Xi Nghezi}

IUPHAR/BPS Guide to PHARMACOLOGY ^{Xi Nghezi}

Guide to Pharmacology Ligand ID ^{Xi Nghezi}

2568

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

ketoconazole (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

MeSH descriptor ID ^{Xi Nghezi}

subject named as ^{Xi Nghezi}

Ketoconazole

0 references

MeSH tree code ^{Xi Nghezi}

D03.383.606.560

0 references

RxNorm ID ^{Xi Nghezi}

6135

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

26 Nyenyenyani 2018

DrugBank ID ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

DrugBank ^{Xi Nghezi}

DrugBank ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

Ketoconazole (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

Human Metabolome Database ID ^{Xi Nghezi}

HMDB0012242

0 references

HMDB0243587

1 reference

based on heuristic ^{Xi Nghezi}

inferred from InChIKey ^{Xi Nghezi}

UNII ^{Xi Nghezi}

R9400W927I

1 reference

stated in ^{Xi Nghezi}

DrugBank ^{Xi Nghezi}

DrugBank ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

ketoconazole-zinc-pyrithione

title ^{Xi Nghezi}

Ketoconazole (Xi Nghezi)

retrieved ^{Xi Nghezi}

4 Nhlangula 2016

MedlinePlus drug identifier ^{Xi Nghezi}

a682816

route of administration ^{Xi Nghezi}

oral administration ^{Xi Nghezi}

0 references

a605014

route of administration ^{Xi Nghezi}

topical medication ^{Xi Nghezi}

0 references

PatientsLikeMe treatment ID ^{Xi Nghezi}

ketoconazole

0 references

0 references

NDF-RT ID ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

NDF-RT ^{Xi Nghezi}

NDF-RT ID ^{Xi Nghezi}

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

KETOCONAZOLE (Xi Nghezi)

retrieved ^{Xi Nghezi}

19 Sunguti 2016

Probes And Drugs ID ^{Xi Nghezi}

PD009589

0 references

DrugCentral ID ^{Xi Nghezi}

1527

1 reference

stated in ^{Xi Nghezi}

UniChem ^{Xi Nghezi}

KEGG ID ^{Xi Nghezi}

D00351

1 reference

stated in ^{Xi Nghezi}

ChEMBL ^{Xi Nghezi}

ChEMBL ID ^{Xi Nghezi}

CHEMBL157101

language of work or name ^{Xi Nghezi}

title ^{Xi Nghezi}

Ketoconazole (Xi Nghezi)

retrieved ^{Xi Nghezi}

19 Sunguti 2016

Brockhaus Enzyklopädie online ID ^{Xi Nghezi}

ketoconazol

0 references

DeCS ID ^{Xi Nghezi}

7819

0 references

Encyclopædia Britannica Online ID ^{Xi Nghezi}

science/ketoconazole

subject named as ^{Xi Nghezi}

ketoconazole

0 references

Encyclopedia of China (Third Edition) ID ^{Xi Nghezi}

298237

0 references

Freebase ID ^{Xi Nghezi}

/m/03bxlz

1 reference

stated in ^{Xi Nghezi}

Freebase Data Dumps ^{Xi Nghezi}

publication date ^{Xi Nghezi}

28 Nhlangula 2013

KBpedia ID ^{Xi Nghezi}

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

stated in ^{Xi Nghezi}

KBpedia ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

9 Mawuwani 2020

Microsoft Academic ID ^{Xi Nghezi}

2781064554

0 references

NALT ID ^{Xi Nghezi}

10321

0 references

OpenAlex ID ^{Xi Nghezi}

C2781064554

1 reference

stated in ^{Xi Nghezi}

OpenAlex ^{Xi Nghezi}

retrieved ^{Xi Nghezi}

26 Sunguti 2022

reference URL ^{Xi Nghezi}

Quora topic ID ^{Xi Nghezi}

1 reference

stated in ^{Xi Nghezi}

Quora ^{Xi Nghezi}

Römpp online ID ^{Xi Nghezi}

RD-11-00945

1 reference

imported from Wikimedia project ^{Xi Nghezi}

German Wikipedia ^{Xi Nghezi}

UNSPSC Code ^{Xi Nghezi}

51101811

0 references

WikiProjectMed ID ^{Xi Nghezi}